Home » Reckitt Benckiser share price slides as group trims growth target

Reckitt Benckiser share price slides as group trims growth target

Tsveta van Son
  • July 30th 2019, 09:23
  • Last Updated: August 5th 2019, 16:59

Reckitt Benckiser’s (LON:RB) share price has fallen into the red in today’s session as the company trimmed its full-year revenue target following weaker-than-expected performance in the first half of the year. The update comes after the consumer goods giant recently reached a $1.4-billion settlement with the US over a probe into the sales and marketing of Suboxone Film by Indivior.

As of 10:06 BST, Reckitt Benckiser’s share price had given up 3.21 percent to 6,456.00p, underperforming the broader UK market, with the benchmark FTSE 100 index currently standing 0.04 percent lower at 7,683.59 points. The group’s shares have given up nearly six percent of their value over the past year, as compared with about a 0.1-percent fall in the Footsie.

Reckitt Benckiser posts interims

Reckitt Benckiser announced in a statement this morning that its like-for-like performance in the second quarter of the year was flat, with a decline in its health segment offsetting a rise in its hygiene home business.

“Our like for like performance in H1 was +1%, somewhat below our expectations,” the company’s outgoing chief executive Rakesh Kapoor commented in the statement, adding that with the slow start to the year and the turnaround in its health division “still work in progress, we are revising our 2019 net revenue target”.

The consumer goods giant now expects to deliver like-for-like growth of between two percent and three percent this year, down from its previous guidance of between three percent and four percent revenue growth.

Analysts on FTSE 100 company

The 20 analysts offering 12-month targets for the Reckitt Benckiser share price have a median target of 7,000.00p, with a high estimate of 9,000.00p and a low estimate of 5,300.00p. As of July 26, the consensus forecast amongst 24 polled investment analysts covering the blue-chip group has it that the company will outperform the market.

About the author

Tsveta van Son
Tsveta van Son is part of Invezz’s journalist team. She has a BA degree in European Studies and a MA degree in Nordic Studies from Sofia University and has also attended the University of Iceland. While she covers a variety of investment news, she is particularly interested in developments in the field of renewable energy.

Leave a Reply

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.